Navigation Links
Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
Date:3/12/2009

cept per share data) Three Months Ended Year Ended December 31, December 31, 2008 2007 2008 2007 Revenue: Product revenue $25,495 $28,175 $85,149 $82,961 Service revenue 8,873 9,513 37,734 37,557 License fees and contract revenue 2,327 2,568 11,171 20,189 Total revenue 36,695 40,256 134,054 140,707 Costs and expenses: Cost of product revenue 15,857 15,961 52,178 49,760 Cost of service revenue 5,604 5,756 24,739 22,357 Cost of license revenue 323 277 1,477 2,515 Research and Development 4,395 5,702 19,921 24,791 Selling, general and administrative 12,043 15,642 48,987 54,954 Impairment of goodwill 43,365 - 43,365 - Amortization of intangible assets 1,592 2,514 8,313 10,106 Restructuring charges, net 1,939 22 4,605 52 Total costs and Expenses 85,118 45,874 203,585 164,535 Operating loss (48,423) (5,618) (69,531) (23,828) Interest expense, net (210) (226) (794) (547) Gain on divestiture of product lines 2,119 - 2,119 - Other income, net 613 213 521 579 Provision for income taxes (378) (103) (607) (284) Net loss $(46,279) $(5,734) $(68,292) $(24,080) Net loss per share, basic and diluted $(0.95) $(0.12) $(1.42) $(0.51) Shares used in computing
'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
2. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
3. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
4. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
5. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
6. Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays
7. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
8. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
9. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
10. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
11. Caliper Life Sciences Reports Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... (PRWEB) July 11, 2014 BCC Research ... DIGITAL POLYMERASE CHAIN REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS ... (PCR) technology reached nearly $140 billion in 2013. This ... registering a five-year compound annual growth rate (CAGR) of ... number of interesting and exciting possibilities within the broader ...
(Date:7/11/2014)... -- Researchers have pioneered a revolutionary new way to ... Virtual Finger, allows scientists to move through digital ... using the flat surface of their computer screens. ... orders of magnitude more efficient, saving time, money ... areas of experimental biology. The software and its ...
(Date:7/10/2014)... 10, 2014 Product and process ... low abundance and are often “lost in the ... , Join presenters Dr. Rowel Tobias, Senior Scientist, ... Anders, Head of Quality at Nanotherapeutics, Inc., to ... can speed detection and quantitation while achieving the ...
(Date:7/10/2014)... Mass. (PRWEB) July 10, 2014 Terascala, ... today announced that Alan Swahn, a former vice president ... executive team as vice president of marketing. Terascala’s software ... Dell and NetApp create the highest performance and most ... been appointed to guide Terascala’s channel expansion and broaden ...
Breaking Biology Technology:Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Terascala Expands Executive Team 2Terascala Expands Executive Team 3
... EMERYVILLE, Calif. , May 4 S*BIO Pte Ltd and ... their development collaboration and option and license commercialization agreement for S*BIO,s novel ... 0805, respectively. The expanded agreement builds upon the development and commercialization collaboration ... , , ...
... 4 Romark Laboratories announced results from its STEALTH C-3 ... patients with genotype 1 chronic hepatitis C.  Study results were presented ... of the American Gastroenterological Association Institute (AGA Institute) during Digestive Disease ... , , ...
... ... Sepha , is challenging traditional thinking on leak testing procedures through ... its new leak-testing technology can increase competiveness and revolutionise current packaging test methods within ... ...
Cached Biology Technology:S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors 2S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors 3S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors 4S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors 5Romark Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C 2Romark Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C 3Romark Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C 4Romark Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C 5Pharmaceutical Leak Testing Practices challenged by SEPHA 2Pharmaceutical Leak Testing Practices challenged by SEPHA 3
(Date:7/11/2014)... evidence has demonstrated that transplantation of mesenchymal stem cells ... or mouse models of Alzheimer,s disease (AD) and improve ... ischemia. Few studies are reported on the therapeutic effect ... AD and on the effect on oxidative injury and ... Yan and her team, School of Life Sciences, Tsinghua ...
(Date:7/11/2014)... cannabinoid receptor type 1 can inhibit voltage-gated ... reduce neurotransmitter release. However, some scholars demonstrated ... extracellular Ca2+ influx and increase neurotransmitter release. ... Hospital Affiliated to Tongji Medical College, Huazhong ... whole cell voltage-clamp and calcium imaging in ...
(Date:7/11/2014)... In the brains of all vertebrates, information is ... electric or chemical signal to be passed from ... are the most abundant type of synapse, can ... crucial for learning, memory, perception and cognition, and ... for brain function. For instance, every time ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2
... U.S. agricultural practices create 58 percent of nitrous oxide ... gas in the atmosphere. Scientists believe nitrous oxide contributes to ... practices and products have been introduced to address this issue, ... to experiment with ideas that may ultimately hurt the "bottom ...
... considered overweight and more than one-third categorized as obese, ... is a major national goal. Mathematical modeling of the ... growing subfield of obesity research, which can be used ... Mathematical and Biological Synthesis (NIMBioS) is now accepting applications ...
... available in German . , "Don,t be a frog!" ... away. However to be called a frog should actually be a ... at least from the point of view of evolutionary biology: ... are superior to all the other amphibians, and even mammals", says ...
Cached Biology News:MU scientists find new farming method to reduce greenhouse gases, increase farm yields 2Body weight regulation and metabolism focus of workshop 2Inventions of evolution: What gives frogs a face 2
... an aqueous solution that contains a purified ... in a MOPS buffer (3-(N-Morpholino) propanesulfonic acid), ... contains a combination of 0.02% methylisothiazolone, 0.02% ... and Haas Company) as a preservative. ...
Preparation Note: by a modification of the procedure of C.W. Hancher et al., Biotechnol. Bioeng. 11, 1055 (1969) Assay: ~ 20 A 260 /mg Solubility: water 10 mg/mL, clear, light-yellow Suitab tst...
Request Info...
This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin...
Biology Products: